TY - JOUR AU - Gestel, Y. R. AU - Hingh, I. H. AU - Herk-Sukel, M. P. AU - Erning, F. N. AU - Beerepoot, L. V. AU - Wijsman, J. H. PY - 2014 DA - 2014// TI - Patterns of metachronous metastases after curative treatment of colorectal cancer JO - Cancer Epidemiol VL - 38 UR - https://doi.org/10.1016/j.canep.2014.04.004 DO - 10.1016/j.canep.2014.04.004 ID - Gestel2014 ER - TY - JOUR AU - Geest, L. G. AU - Lam-Boer, J. AU - Koopman, M. AU - Verhoef, C. AU - Elferink, M. A. AU - Wilt, J. H. PY - 2015 DA - 2015// TI - Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases JO - Clin Exp Metastasis VL - 32 UR - https://doi.org/10.1007/s10585-015-9719-0 DO - 10.1007/s10585-015-9719-0 ID - Geest2015 ER - TY - JOUR AU - Lemmens, V. E. AU - Klaver, Y. L. AU - Verwaal, V. J. AU - Rutten, H. J. AU - Coebergh, J. W. AU - Hingh, I. H. PY - 2011 DA - 2011// TI - Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study JO - Int J Cancer VL - 128 UR - https://doi.org/10.1002/ijc.25596 DO - 10.1002/ijc.25596 ID - Lemmens2011 ER - TY - JOUR AU - Gestel, Y. R. AU - Thomassen, I. AU - Lemmens, V. E. AU - Pruijt, J. F. AU - Herk-Sukel, M. P. AU - Rutten, H. J. PY - 2014 DA - 2014// TI - Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer JO - Eur J Surg Oncol VL - 40 ID - Gestel2014 ER - TY - JOUR AU - Quere, P. AU - Facy, O. AU - Manfredi, S. AU - Jooste, V. AU - Faivre, J. AU - Lepage, C. PY - 2015 DA - 2015// TI - Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study JO - Dis Colon Rectum VL - 58 UR - https://doi.org/10.1097/DCR.0000000000000412 DO - 10.1097/DCR.0000000000000412 ID - Quere2015 ER - TY - JOUR AU - Razenberg, L. G. AU - Lemmens, V. E. AU - Verwaal, V. J. AU - Punt, C. J. AU - Tanis, P. J. AU - Creemers, G. J. PY - 2016 DA - 2016// TI - Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: results of a population-based study JO - Eur J Cancer VL - 65 UR - https://doi.org/10.1016/j.ejca.2016.07.002 DO - 10.1016/j.ejca.2016.07.002 ID - Razenberg2016 ER - TY - JOUR AU - Baratti, D. AU - Kusamura, S. AU - Pietrantonio, F. AU - Guaglio, M. AU - Niger, M. AU - Deraco, M. PY - 2016 DA - 2016// TI - Progress in treatments for colorectal cancer peritoneal metastases during the years 2010–2015. A systematic review JO - Crit Rev Oncol Hematol VL - 100 UR - https://doi.org/10.1016/j.critrevonc.2016.01.017 DO - 10.1016/j.critrevonc.2016.01.017 ID - Baratti2016 ER - TY - JOUR AU - Goéré, D. AU - Malka, D. AU - Tzanis, D. AU - Gava, V. AU - Boige, V. AU - Eveno, C. PY - 2013 DA - 2013// TI - Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? JO - Ann Surg VL - 257 UR - https://doi.org/10.1097/SLA.0b013e31827e9289 DO - 10.1097/SLA.0b013e31827e9289 ID - Goéré2013 ER - TY - JOUR AU - Klaver, C. E. AU - Groenen, H. AU - Morton, D. G. AU - Laurberg, S. AU - Bemelman, W. A. AU - Tanis, P. J. PY - 2017 DA - 2017// TI - Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines JO - Colorectal Dis VL - 19 UR - https://doi.org/10.1111/codi.13593 DO - 10.1111/codi.13593 ID - Klaver2017 ER - TY - JOUR AU - Yan, T. D. AU - Black, D. AU - Savady, R. AU - Sugarbaker, P. H. PY - 2006 DA - 2006// TI - Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.07.1142 DO - 10.1200/JCO.2006.07.1142 ID - Yan2006 ER - TY - JOUR AU - Cao, C. AU - Yan, T. D. AU - Black, D. AU - Morris, D. L. PY - 2009 DA - 2009// TI - A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin JO - Ann Surg Oncol VL - 16 UR - https://doi.org/10.1245/s10434-009-0487-4 DO - 10.1245/s10434-009-0487-4 ID - Cao2009 ER - TY - STD TI - Landelijke werkgroep Gastro Intestinale Tumoren. Richtlijn colorectaal carcinoom. 2014. https://www.oncoline.nl/colorectaalcarcinoom. Accessed 10 Dec 2018. UR - https://www.oncoline.nl/colorectaalcarcinoom ID - ref12 ER - TY - JOUR AU - Braam, H. J. AU - Oudheusden, T. R. AU - Hingh, I. H. AU - Nienhuijs, S. W. AU - Boerma, D. AU - Wiezer, M. J. PY - 2014 DA - 2014// TI - Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer JO - J Surg Oncol VL - 109 UR - https://doi.org/10.1002/jso.23597 DO - 10.1002/jso.23597 ID - Braam2014 ER - TY - JOUR AU - Kwakman, R. AU - Schrama, A. M. AU - Olmen, J. P. AU - Otten, R. H. AU - Lange-De Klerk, E. S. AU - Cuba, E. M. PY - 2016 DA - 2016// TI - Clinicopathological parameters in patients election for cytoreductve surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis JO - Ann Surg VL - 263 UR - https://doi.org/10.1097/SLA.0000000000001593 DO - 10.1097/SLA.0000000000001593 ID - Kwakman2016 ER - TY - JOUR AU - Passot, G. AU - Vaudoyer, D. AU - Cotte, E. AU - You, B. AU - Isaac, C. AU - Gilly, F. N. PY - 2012 DA - 2012// TI - Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis JO - Ann Surg VL - 256 UR - https://doi.org/10.1097/SLA.0b013e318255486a DO - 10.1097/SLA.0b013e318255486a ID - Passot2012 ER - TY - JOUR AU - Passot, G. AU - You, B. AU - Boschetti, G. AU - Fontaine, J. AU - Isaac, S. AU - Decullier, E. PY - 2014 DA - 2014// TI - Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis JO - Ann Surg Oncol VL - 21 UR - https://doi.org/10.1245/s10434-014-3647-0 DO - 10.1245/s10434-014-3647-0 ID - Passot2014 ER - TY - JOUR AU - Elias, D. AU - Gilly, F. AU - Boutitie, F. AU - Quenet, F. AU - Bereder, J. M. AU - Mansvelt, B. PY - 2010 DA - 2010// TI - Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study JO - J Clin Oncol. VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.9285 DO - 10.1200/JCO.2009.23.9285 ID - Elias2010 ER - TY - JOUR AU - Baratti, D. AU - Kusamura, S. AU - Iusco, D. AU - Bonomi, S. AU - Grassi, A. AU - Virzi, S. PY - 2014 DA - 2014// TI - Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients JO - Dis Colon Rectum VL - 57 UR - https://doi.org/10.1097/DCR.0000000000000149 DO - 10.1097/DCR.0000000000000149 ID - Baratti2014 ER - TY - JOUR AU - Mitry, E. AU - Fields, A. L. AU - Bleiberg, H. AU - Labianca, R. AU - Portier, G. AU - Tu, D. PY - 2008 DA - 2008// TI - Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials JO - J Clin Oncol. VL - 26 UR - https://doi.org/10.1200/JCO.2008.17.3781 DO - 10.1200/JCO.2008.17.3781 ID - Mitry2008 ER - TY - JOUR AU - Elias, D. AU - Lefevre, J. H. AU - Chevalier, J. AU - Brouquet, A. AU - Marchal, F. AU - Classe, J. M. PY - 2009 DA - 2009// TI - Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin JO - J Clin Oncol. VL - 27 UR - https://doi.org/10.1200/JCO.2008.19.7160 DO - 10.1200/JCO.2008.19.7160 ID - Elias2009 ER - TY - JOUR AU - Devilee, R. A. AU - Simkens, G. A. AU - Oudheusden, T. R. AU - Rutten, H. J. AU - Creemers, G. J. AU - Tije, A. J. PY - 2016 DA - 2016// TI - Increased survival of patients with synchronous colorectal peritoneal metastases receiving preoperative chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy JO - Ann Surg Oncol. VL - 23 UR - https://doi.org/10.1245/s10434-016-5214-3 DO - 10.1245/s10434-016-5214-3 ID - Devilee2016 ER - TY - JOUR AU - Franko, J. AU - Shi, Q. AU - Meyers, J. P. AU - Maughan, T. S. AU - Adams, R. A. AU - Seymour, M. T. PY - 2016 DA - 2016// TI - Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database JO - Lancet Oncol. VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30500-9 DO - 10.1016/S1470-2045(16)30500-9 ID - Franko2016 ER - TY - JOUR AU - Klaver, Y. L. AU - Simkens, L. H. AU - Lemmens, V. E. AU - Koopman, M. AU - Teerenstra, S. AU - Bleichrodt, R. P. PY - 2012 DA - 2012// TI - Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy JO - Eur J Surg Oncol. VL - 38 UR - https://doi.org/10.1016/j.ejso.2012.03.008 DO - 10.1016/j.ejso.2012.03.008 ID - Klaver2012 ER - TY - JOUR AU - Sugarbaker, P. H. AU - Stuart, O. H. AU - Vidal-Jove, J. AU - Pessagno, A. M. AU - Bruijn, E. A. PY - 1996 DA - 1996// TI - Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration JO - Cancer Treat Res. VL - 82 UR - https://doi.org/10.1007/978-1-4613-1247-5_3 DO - 10.1007/978-1-4613-1247-5_3 ID - Sugarbaker1996 ER - TY - JOUR AU - Hompes, D. AU - Aalbers, A. AU - Boot, H. AU - Velthuysen, M. L. AU - Vogel, W. AU - Prevoo, W. PY - 2014 DA - 2014// TI - A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer JO - Colorectal Dis. VL - 16 UR - https://doi.org/10.1111/codi.12560 DO - 10.1111/codi.12560 ID - Hompes2014 ER - TY - JOUR AU - Glockzin, G. AU - Zeman, F. AU - Croner, R. S. AU - Königsrainer, A. AU - Pelz, J. AU - Ströhlein, M. A. PY - 2018 DA - 2018// TI - Perioperative systemic chemotherapy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy in patients with colorectal peritoneal metastasis: results of the prospective multicenter phase 2 COMBATAC trial JO - Clin Colorectal Cancer. VL - 17 UR - https://doi.org/10.1016/j.clcc.2018.07.011 DO - 10.1016/j.clcc.2018.07.011 ID - Glockzin2018 ER - TY - JOUR AU - Nordlinger, B. AU - Sorbye, H. AU - Glimelius, B. AU - Poston, G. J. AU - Schlag, P. M. AU - Rougier, P. PY - 2008 DA - 2008// TI - Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Integroup trial 40983): a randomised controlled trial JO - Lancet. VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60455-9 DO - 10.1016/S0140-6736(08)60455-9 ID - Nordlinger2008 ER - TY - JOUR AU - Nordlinger, B. AU - Sorbye, H. AU - Glimelius, B. AU - Poston, G. J. AU - Schlag, P. M. AU - Rougier, P. PY - 2013 DA - 2013// TI - Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised controlled, phase 3 trial JO - Lancet Oncol. VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70447-9 DO - 10.1016/S1470-2045(13)70447-9 ID - Nordlinger2013 ER - TY - JOUR AU - Niraula, S. AU - Seruga, B. AU - Ocana, A. AU - Shao, T. AU - Goldstein, R. AU - Tannock, I. F. PY - 2012 DA - 2012// TI - The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs JO - J Clin Oncol. VL - 3 ID - Niraula2012 ER - TY - JOUR AU - Eveno, C. AU - Passot, G. AU - Goéré, D. AU - Soyer, P. AU - Gayat, E. AU - Glehen, O. PY - 2014 DA - 2014// TI - Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin JO - Ann Surg Oncol. VL - 21 UR - https://doi.org/10.1245/s10434-013-3442-3 DO - 10.1245/s10434-013-3442-3 ID - Eveno2014 ER - TY - JOUR AU - Niraula, S. AU - Amir, E. AU - Vera-Badillo, F. AU - Seruga, B. AU - Ocana, A. AU - Tannock, I. F. PY - 2014 DA - 2014// TI - Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis JO - J Clin Oncol. VL - 32 UR - https://doi.org/10.1200/JCO.2014.55.8437 DO - 10.1200/JCO.2014.55.8437 ID - Niraula2014 ER - TY - JOUR AU - Shih, Y. C. AU - Smieliauskas, F. AU - Geynisman, D. M. AU - Kelly, R. J. AU - Smith, T. J. PY - 2015 DA - 2015// TI - Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011 JO - J Clin Oncol. VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.2320 DO - 10.1200/JCO.2014.58.2320 ID - Shih2015 ER - TY - JOUR AU - Rovers, K. P. AU - Simkens, G. A. AU - Punt, C. J. AU - Dieren, S. AU - Tanis, P. J. AU - Hingh, I. H. PY - 2017 DA - 2017// TI - Perioperative systemic therapy for resectable colorectal peritoneal metastases: sufficient evidence for its widespread use? A critical systematic review JO - Crit Rev Oncol Hematol. VL - 114 UR - https://doi.org/10.1016/j.critrevonc.2017.03.028 DO - 10.1016/j.critrevonc.2017.03.028 ID - Rovers2017 ER - TY - JOUR AU - Bushati, M. AU - Rovers, K. P. AU - Sommariva, A. AU - Sugarbaker, P. H. AU - Morris, D. L. AU - Yonemura, Y. PY - 2018 DA - 2018// TI - The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI) JO - Eur J Surg Oncol. VL - 44 UR - https://doi.org/10.1016/j.ejso.2018.07.003 DO - 10.1016/j.ejso.2018.07.003 ID - Bushati2018 ER - TY - JOUR AU - Esquivel, J. AU - Sticca, R. AU - Sugarbaker, P. AU - Levine, E. AU - Yan, T. D. AU - Alexander, R. PY - 2007 DA - 2007// TI - Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology JO - Ann Surg Oncol. VL - 14 UR - https://doi.org/10.1245/s10434-006-9185-7 DO - 10.1245/s10434-006-9185-7 ID - Esquivel2007 ER - TY - JOUR AU - Maillet, M. AU - Glehen, O. AU - Lambert, J. AU - Goéré, D. AU - Pocard, M. AU - Msika, S. PY - 2016 DA - 2016// TI - Early postoperative chemotherapy after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for isolated peritoneal carcinomatosis of colon cancer: a multicenter study JO - Ann Surg Oncol. VL - 23 UR - https://doi.org/10.1245/s10434-015-4914-4 DO - 10.1245/s10434-015-4914-4 ID - Maillet2016 ER - TY - JOUR AU - Sauer, R. AU - Becker, H. AU - Hohenberger, W. AU - Rödel, C. AU - Wittekind, C. AU - Fietkau, R. PY - 2004 DA - 2004// TI - Preoperative versus postoperative chemoradiotherapy for rectal cancer JO - N Engl J Med. VL - 351 UR - https://doi.org/10.1056/NEJMoa040694 DO - 10.1056/NEJMoa040694 ID - Sauer2004 ER - TY - JOUR AU - Cunningham, D. AU - Allum, W. H. AU - Stenning, S. P. AU - Thompson, J. N. AU - Velde, C. J. AU - Nicolson, M. PY - 2006 DA - 2006// TI - Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer JO - N Engl J Med. VL - 355 UR - https://doi.org/10.1056/NEJMoa055531 DO - 10.1056/NEJMoa055531 ID - Cunningham2006 ER - TY - JOUR AU - Hagen, P. AU - Hulshof, M. C. AU - Lanschot, J. J. AU - Steyerberg, E. W. AU - Berge Henegouwen, M. I. AU - Wijnhoven, B. P. PY - 2012 DA - 2012// TI - Preoperative chemoradiotherapy for esophageal or junctional cancer JO - N Engl J Med. VL - 366 UR - https://doi.org/10.1056/NEJMoa1112088 DO - 10.1056/NEJMoa1112088 ID - Hagen2012 ER - TY - JOUR AU - Gramont, A. AU - Figer, A. AU - Seymour, M. AU - Homerin, M. AU - Hmissi, A. AU - Cassidy, J. PY - 2000 DA - 2000// TI - Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer JO - J Clin Oncol. VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.16.2938 DO - 10.1200/JCO.2000.18.16.2938 ID - Gramont2000 ER - TY - JOUR AU - Giacchetti, S. AU - Perpoint, B. AU - Zidani, R. AU - Bail, N. AU - Faggiuolo, R. AU - Focan, C. PY - 2000 DA - 2000// TI - Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer JO - J Clin Oncol. VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.1.136 DO - 10.1200/JCO.2000.18.1.136 ID - Giacchetti2000 ER - TY - JOUR AU - Saltz, L. B. AU - Cox, J. V. AU - Blanke, C. AU - Rosen, L. S. AU - Fehrenbacher, L. AU - Moore, M. J. PY - 2000 DA - 2000// TI - Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group JO - N Engl J Med. VL - 343 UR - https://doi.org/10.1056/NEJM200009283431302 DO - 10.1056/NEJM200009283431302 ID - Saltz2000 ER - TY - JOUR AU - Douillard, J. Y. AU - Cunningham, D. AU - Roth, A. D. AU - Navarro, M. AU - James, R. D. AU - Karasek, P. PY - 2000 DA - 2000// TI - Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomised trial JO - Lancet. VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02034-1 DO - 10.1016/S0140-6736(00)02034-1 ID - Douillard2000 ER - TY - JOUR AU - Sobrero, A. AU - Bennicelli, E. PY - 2010 DA - 2010// TI - Chemotherapy: which drug and when? JO - Ann Oncol. VL - 21 UR - https://doi.org/10.1093/annonc/mdq293 DO - 10.1093/annonc/mdq293 ID - Sobrero2010 ER - TY - JOUR AU - Koopman, M. AU - Antonini, N. F. AU - Douma, J. AU - Wals, J. AU - Honkoop, A. H. AU - Erdkamp, F. L. PY - 2007 DA - 2007// TI - Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial JO - Lancet. VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61086-1 DO - 10.1016/S0140-6736(07)61086-1 ID - Koopman2007 ER - TY - JOUR AU - Fuchs, C. S. AU - Marshall, J. AU - Mitchell, E. AU - Wierzbicki, R. AU - Ganju, V. AU - Jeffery, M. PY - 2007 DA - 2007// TI - Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C study JO - J Clin Oncol. VL - 25 UR - https://doi.org/10.1200/JCO.2007.11.3357 DO - 10.1200/JCO.2007.11.3357 ID - Fuchs2007 ER - TY - JOUR AU - Köhne, C. H. AU - Greve, J. AU - Hartmann, J. T. AU - Lang, I. AU - Vergauwe, P. AU - Becker, K. PY - 2008 DA - 2008// TI - Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015 JO - Ann Oncol. VL - 19 UR - https://doi.org/10.1093/annonc/mdm544 DO - 10.1093/annonc/mdm544 ID - Köhne2008 ER - TY - JOUR AU - Falcone, A. AU - Ricci, S. AU - Brunetti, I. AU - Pfanner, E. AU - Allegrini, G. AU - Barbara, C. PY - 2007 DA - 2007// TI - Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest JO - J Clin Oncol. VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.0928 DO - 10.1200/JCO.2006.09.0928 ID - Falcone2007 ER - TY - STD TI - Chan DL, Segelov E, Wong RS, Smith A, Herbertson RA, Li BT, et al. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. Cochrane Database Syst Rev. 2017;(6):CD007047. ID - ref49 ER - TY - STD TI - Wagner AD, Arnold D, Grothey AA, Haerting J, Unverzagt S. Anti-angiogenic therapies for metastatic colorectal cancer. Cochrane Database Syst Rev. 2009;(3):CD005392. ID - ref50 ER - TY - JOUR AU - Heinemann, V. AU - Weikersthal, L. F. AU - Decker, T. AU - Kiani, A. AU - Vehling-Kaiser, U. AU - Al-Batran, S. E. PY - 2014 DA - 2014// TI - FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial JO - Lancet Oncol. VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70330-4 DO - 10.1016/S1470-2045(14)70330-4 ID - Heinemann2014 ER - TY - JOUR AU - Schwartzberg, L. S. AU - Rivera, F. AU - Karthaus, M. AU - Fasola, G. AU - Canon, J. L. AU - Hecht, J. R. PY - 2014 DA - 2014// TI - PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer JO - J Clin Oncol. VL - 32 UR - https://doi.org/10.1200/JCO.2013.53.2473 DO - 10.1200/JCO.2013.53.2473 ID - Schwartzberg2014 ER - TY - JOUR AU - Venook, A. P. AU - Niedzwiecki, D. AU - Lenz, H. J. AU - Innocenti, F. AU - Fruth, B. AU - Meyerhardt, J. A. PY - 2017 DA - 2017// TI - Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial JO - JAMA. VL - 317 UR - https://doi.org/10.1001/jama.2017.7105 DO - 10.1001/jama.2017.7105 ID - Venook2017 ER - TY - JOUR AU - Primrose, J. AU - Falk, S. AU - Finch-Jones, M. AU - Valle, J. AU - O’Reilly, D. AU - Siriwardena, A. AU - Hornbuckle, J. PY - 2014 DA - 2014// TI - Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the new EPOC randomised controlled trial JO - Lancet Oncol. VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70105-6 DO - 10.1016/S1470-2045(14)70105-6 ID - Primrose2014 ER - TY - JOUR AU - Ceelen, W. AU - Nieuwenhove, Y. AU - Putte, D. V. AU - Pattyn, P. PY - 2014 DA - 2014// TI - Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis JO - Ann Surg Oncol. VL - 21 UR - https://doi.org/10.1245/s10434-014-3713-7 DO - 10.1245/s10434-014-3713-7 ID - Ceelen2014 ER - TY - JOUR AU - Gremonprez, F. AU - Descamps, B. AU - Izmer, A. AU - Vanhove, C. AU - Vanhaecke, F. AU - Wever, O. PY - 2015 DA - 2015// TI - Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.5092 DO - 10.18632/oncotarget.5092 ID - Gremonprez2015 ER - TY - JOUR AU - Tol, J. AU - Koopman, M. AU - Cats, A. AU - Rodenburg, C. J. AU - Creemers, G. J. AU - Schrama, J. G. PY - 2009 DA - 2009// TI - Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer JO - N Engl J Med. VL - 360 UR - https://doi.org/10.1056/NEJMoa0808268 DO - 10.1056/NEJMoa0808268 ID - Tol2009 ER - TY - JOUR AU - Hecht, J. R. AU - Mitchell, E. AU - Chidiac, T. AU - Scroggin, C. AU - Hagenstad, C. AU - Spigel, D. PY - 2009 DA - 2009// TI - A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer JO - J Clin Oncol. VL - 27 UR - https://doi.org/10.1200/JCO.2008.19.8135 DO - 10.1200/JCO.2008.19.8135 ID - Hecht2009 ER - TY - JOUR AU - Wilkinson, N. W. AU - Yothers, G. AU - Lopa, S. AU - Constantino, J. P. AU - Petrelli, N. J. AU - Wolmark, N. PY - 2010 DA - 2010// TI - Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials JO - Ann Surg Oncol. VL - 17 UR - https://doi.org/10.1245/s10434-009-0881-y DO - 10.1245/s10434-009-0881-y ID - Wilkinson2010 ER - TY - JOUR AU - Gray, R. AU - Barnwell, J. AU - McConkey, C. AU - Hills, R. K. AU - Williams, N. S. AU - Kerr, D. J. PY - 2007 DA - 2007// TI - Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study JO - Lancet. VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61058-7 DO - 10.1016/S0140-6736(07)61058-7 ID - Gray2007 ER - TY - JOUR AU - Twelves, C. AU - Wong, A. AU - Nowacki, M. P. AU - Abt, M. AU - Burris, H. AU - Carrato, A. PY - 2005 DA - 2005// TI - Capecitabine as adjuvant treatment for stage III colon cancer JO - N Engl J Med. VL - 352 UR - https://doi.org/10.1056/NEJMoa043116 DO - 10.1056/NEJMoa043116 ID - Twelves2005 ER - TY - JOUR AU - André, T. AU - Gramont, A. AU - Vernerey, D. AU - Chibaudel, B. AU - Bonnetain, F. AU - Tijeras-Raballand, A. PY - 2015 DA - 2015// TI - Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study JO - J Clin Oncol. VL - 33 UR - https://doi.org/10.1200/JCO.2015.63.4238 DO - 10.1200/JCO.2015.63.4238 ID - André2015 ER - TY - JOUR AU - Schmoll, H. J. AU - Tabernero, J. AU - Maroun, J. AU - Braud, F. AU - Price, T. AU - Cutsem, E. PY - 2015 DA - 2015// TI - Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trial JO - J Clin Oncol. VL - 33 UR - https://doi.org/10.1200/JCO.2015.60.9107 DO - 10.1200/JCO.2015.60.9107 ID - Schmoll2015 ER - TY - JOUR AU - Yothers, G. AU - O’Connell, M. J. AU - Allegra, C. J. AU - Kuebler, J. P. AU - Colangelo, L. H. AU - Petrelli, N. J. PY - 2011 DA - 2011// TI - Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2011.36.4539 DO - 10.1200/JCO.2011.36.4539 ID - Yothers2011 ER - TY - JOUR AU - Saltz, L. B. AU - Niedzwiecki, D. AU - Hollis, D. AU - Goldberg, R. M. AU - Hantel, A. AU - Thomas, J. P. PY - 2007 DA - 2007// TI - Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803 JO - J Clin Oncol. VL - 25 UR - https://doi.org/10.1200/JCO.2007.11.2144 DO - 10.1200/JCO.2007.11.2144 ID - Saltz2007 ER - TY - JOUR AU - Cutsem, E. AU - Labianca, R. AU - Bodoky, G. AU - Barone, C. AU - Aranda, E. AU - Nordlinger, B. PY - 2009 DA - 2009// TI - Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3 JO - J Clin Oncol. VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.6663 DO - 10.1200/JCO.2008.21.6663 ID - Cutsem2009 ER - TY - JOUR AU - Ychou, M. AU - Raoul, J. L. AU - Douillard, J. Y. AU - Gourgou-Bourgade, S. AU - Bugat, R. AU - Mineur, L. PY - 2009 DA - 2009// TI - A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) JO - Ann Oncol. VL - 20 UR - https://doi.org/10.1093/annonc/mdn680 DO - 10.1093/annonc/mdn680 ID - Ychou2009 ER - TY - JOUR AU - Ychou, M. AU - Hohenberger, W. AU - Thezenas, S. AU - Navarro, M. AU - Maurel, J. AU - Bokemeyer, C. PY - 2009 DA - 2009// TI - A randomized phase III study comparing adjuvant 5-fluoruoracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer JO - Ann Oncol. VL - 20 UR - https://doi.org/10.1093/annonc/mdp236 DO - 10.1093/annonc/mdp236 ID - Ychou2009 ER - TY - JOUR AU - Gramont, A. AU - Cutsem, E. AU - Schmoll, H. J. AU - Tabernero, J. AU - Clarke, S. AU - Moore, M. J. PY - 2012 DA - 2012// TI - Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial JO - Lancet Oncol. VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70509-0 DO - 10.1016/S1470-2045(12)70509-0 ID - Gramont2012 ER - TY - JOUR AU - Alberts, S. R. AU - Sargent, D. J. AU - Nair, S. AU - Mahoney, M. R. AU - Mooney, M. AU - Thibodeau, S. N. PY - 2012 DA - 2012// TI - Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial JO - JAMA. VL - 307 UR - https://doi.org/10.1001/jama.2012.7265 DO - 10.1001/jama.2012.7265 ID - Alberts2012 ER - TY - JOUR AU - Taieb, J. AU - Tabernero, J. AU - Mini, E. AU - Subtil, F. AU - Folprecht, G. AU - Laethem, J. L. PY - 2014 DA - 2014// TI - Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial JO - Lancet Oncol. VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70227-X DO - 10.1016/S1470-2045(14)70227-X ID - Taieb2014 ER - TY - JOUR AU - Allegra, C. J. AU - Yothers, G. AU - O’Connell, M. J. AU - Sharif, S. AU - Petrelli, N. J. AU - Colangelo, L. H. PY - 2011 DA - 2011// TI - Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08 JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2010.30.0855 DO - 10.1200/JCO.2010.30.0855 ID - Allegra2011 ER - TY - JOUR AU - Kerr, R. S. AU - Love, S. AU - Segelov, E. AU - Johnstone, E. AU - Falcon, B. AU - Hewett, P. PY - 2016 DA - 2016// TI - Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial JO - Lancet Oncol. VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30172-3 DO - 10.1016/S1470-2045(16)30172-3 ID - Kerr2016 ER - TY - JOUR PY - 2012 DA - 2012// TI - Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial JO - Lancet Oncol. VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70348-0 DO - 10.1016/S1470-2045(12)70348-0 ID - ref74 ER - TY - JOUR AU - Chan, A. W. AU - Tetzlaff, J. M. AU - Altman, D. G. AU - Laupacis, A. AU - Götzsche, P. C. AU - Krle A-Jeric, K. PY - 2013 DA - 2013// TI - SPIRIT 2013 statement: defining standard protocol items for clinical trials JO - Ann Intern Med. VL - 158 UR - https://doi.org/10.7326/0003-4819-158-3-201302050-00583 DO - 10.7326/0003-4819-158-3-201302050-00583 ID - Chan2013 ER - TY - JOUR AU - Jacquet, P. AU - Sugarbaker, P. H. PY - 1996 DA - 1996// TI - Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis JO - Cancer Treat Res. VL - 82 UR - https://doi.org/10.1007/978-1-4613-1247-5_23 DO - 10.1007/978-1-4613-1247-5_23 ID - Jacquet1996 ER - TY - JOUR AU - Kuijpers, A. M. AU - Mirck, B. AU - Aalbers, A. G. AU - Nienhuijs, S. W. AU - Hingh, I. H. AU - Wiezer, M. J. PY - 2013 DA - 2013// TI - Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol JO - Ann Surg Oncol. VL - 20 UR - https://doi.org/10.1245/s10434-013-3145-9 DO - 10.1245/s10434-013-3145-9 ID - Kuijpers2013 ER - TY - JOUR AU - Eden, W. J. AU - Kok, N. F. AU - Woensdregt, K. AU - Huitema, A. D. AU - Boot, H. AU - Aalbers, A. G. PY - 2018 DA - 2018// TI - Safety of intraperitoneal mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC JO - Eur J Surg Oncol. VL - 44 UR - https://doi.org/10.1016/j.ejso.2017.10.216 DO - 10.1016/j.ejso.2017.10.216 ID - Eden2018 ER - TY - JOUR AU - Hompes, D. AU - D’Hoore, A. AU - Wolthuis, A. AU - Fieuws, S. AU - Mirck, B. AU - Bruin, S. PY - 2014 DA - 2014// TI - The use of oxaliplatin or mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study JO - J Surg Oncol. VL - 109 UR - https://doi.org/10.1002/jso.23546 DO - 10.1002/jso.23546 ID - Hompes2014 ER - TY - JOUR AU - Hompes, D. AU - Ruers, T. PY - 2011 DA - 2011// TI - Review: incidence and clinical significance of bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer JO - Eur J Surg Oncol. VL - 37 UR - https://doi.org/10.1016/j.ejso.2011.06.004 DO - 10.1016/j.ejso.2011.06.004 ID - Hompes2011 ER - TY - JOUR AU - Herdman, M. AU - Gudex, C. AU - Lloyd, A. AU - Janssen, M. AU - Kind, P. AU - Parkin, D. PY - 2011 DA - 2011// TI - Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) JO - Qual Life Res. VL - 20 UR - https://doi.org/10.1007/s11136-011-9903-x DO - 10.1007/s11136-011-9903-x ID - Herdman2011 ER - TY - JOUR AU - Versteegh, M. AU - Vermeulen, K. AU - Evers, S. AU - Wit, G. A. AU - Prenger, R. AU - Stolk, E. PY - 2016 DA - 2016// TI - Dutch tariff for the five-level version of EQ-5D JO - Value Health. VL - 19 UR - https://doi.org/10.1016/j.jval.2016.01.003 DO - 10.1016/j.jval.2016.01.003 ID - Versteegh2016 ER - TY - JOUR AU - Aaronson, N. K. AU - Ahmedzai, S. AU - Bergman, B. AU - Bullinger, M. AU - Cull, A. AU - Duez, N. J. PY - 1993 DA - 1993// TI - The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology JO - J Natl Cancer Inst. VL - 85 UR - https://doi.org/10.1093/jnci/85.5.365 DO - 10.1093/jnci/85.5.365 ID - Aaronson1993 ER - TY - JOUR AU - Stiggelbout, A. M. AU - Kunneman, M. AU - Baas-Thijssen, M. C. AU - Neijenhuis, P. A. AU - Loor, A. K. AU - Jägers, S. PY - 2016 DA - 2016// TI - The EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer: validation of the Dutch version JO - Qual Life Res. VL - 25 UR - https://doi.org/10.1007/s11136-015-1210-5 DO - 10.1007/s11136-015-1210-5 ID - Stiggelbout2016 ER - TY - JOUR AU - Bouwmans, C. AU - Krol, M. AU - Severens, H. AU - Koopmanschap, M. AU - Brouwer, W. AU - Hakkaart-van Roijen, L. PY - 2015 DA - 2015// TI - The iMTA Productivity Cost Questionnaire: a standardized instrument for measuring and valuing health-related productivity losses JO - Value Health VL - 18 UR - https://doi.org/10.1016/j.jval.2015.05.009 DO - 10.1016/j.jval.2015.05.009 ID - Bouwmans2015 ER - TY - STD TI - iMTA: questionnaires. https://www.imta.nl/questionnaires/. Accessed 10 Dec 2018. UR - https://www.imta.nl/questionnaires/ ID - ref86 ER - TY - STD TI - Common Terminology Criteria for Adverse Events (CTCAE) v4.0. National Cancer Institute. 2009. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf. Accessed 10 Dec 2018. UR - https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf ID - ref87 ER - TY - JOUR AU - Dindo, D. AU - Demartines, N. AU - Clavien, P. A. PY - 2004 DA - 2004// TI - Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey JO - Ann Surg. VL - 240 UR - https://doi.org/10.1097/01.sla.0000133083.54934.ae DO - 10.1097/01.sla.0000133083.54934.ae ID - Dindo2004 ER - TY - JOUR AU - Chua, T. C. AU - Morris, D. L. AU - Saxena, A. AU - Esquivel, J. AU - Liauw, W. AU - Doerfer, J. PY - 2011 DA - 2011// TI - Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study JO - Ann Surg Oncol. VL - 18 UR - https://doi.org/10.1245/s10434-010-1522-1 DO - 10.1245/s10434-010-1522-1 ID - Chua2011 ER - TY - JOUR AU - Kuijpers, A. M. AU - Mehta, A. M. AU - Boot, H. AU - Leerdam, M. E. AU - Hauptmann, M. AU - Aalbers, A. G. PY - 2014 DA - 2014// TI - Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy JO - Ann Oncol. VL - 25 UR - https://doi.org/10.1093/annonc/mdu031 DO - 10.1093/annonc/mdu031 ID - Kuijpers2014 ER - TY - JOUR AU - Eden, W. J. AU - Kok, N. F. AU - Józwiak, K. AU - Lahaye, M. L. AU - Geets, G. L. AU - Leerdam, M. E. PY - 2017 DA - 2017// TI - Timing of systemic chemotherapy in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy JO - Dis Colon Rectum VL - 60 UR - https://doi.org/10.1097/DCR.0000000000000774 DO - 10.1097/DCR.0000000000000774 ID - Eden2017 ER - TY - STD TI - Dutch Colorectal Cancer Group. CAIRO6. 2017. https://dccg.nl/trial/cairo-6. Accessed 10 Dec 2018. UR - https://dccg.nl/trial/cairo-6 ID - ref92 ER - TY - JOUR AU - Willaert, W. AU - Speeten, K. AU - Liberale, G. AU - Ceelen, W. PY - 2015 DA - 2015// TI - BEV-IP: perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis JO - BMC Cancer. VL - 15 UR - https://doi.org/10.1186/s12885-015-1954-x DO - 10.1186/s12885-015-1954-x ID - Willaert2015 ER - TY - JOUR AU - Passot, G. AU - Dumont, F. AU - Goéré, D. AU - Arvieux, C. AU - Rousset, P. PY - 2018 DA - 2018// TI - Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE) JO - Br J Surg. VL - 105 UR - https://doi.org/10.1002/bjs.10723 DO - 10.1002/bjs.10723 ID - Passot2018 ER - TY - JOUR AU - Bree, E. AU - Koops, W. AU - Kröger, R. AU - Ruth, S. AU - Witkamp, A. J. AU - Zoetmulder, F. A. PY - 2004 DA - 2004// TI - Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement JO - J Surg Oncol. VL - 85 UR - https://doi.org/10.1002/jso.20049 DO - 10.1002/jso.20049 ID - Bree2004 ER - TY - JOUR AU - Koh, J. L. AU - Yan, T. D. AU - Glenn, D. AU - Morris, D. L. PY - 2009 DA - 2009// TI - Evaluation of preoperative computed tompography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis JO - Ann Surg Oncol. VL - 16 UR - https://doi.org/10.1245/s10434-008-0234-2 DO - 10.1245/s10434-008-0234-2 ID - Koh2009 ER - TY - JOUR AU - Esquivel, J. AU - Chua, T. C. AU - Stojadinovic, A. AU - Melero, J. T. AU - Levine, E. A. AU - Gutman, M. PY - 2012 DA - 2012// TI - Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal canacer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study JO - J Surg Oncol. VL - 102 UR - https://doi.org/10.1002/jso.21601 DO - 10.1002/jso.21601 ID - Esquivel2012 ER - TY - STD TI - van 't Sant I, van Eden WJ, Engbersen MP, Kok NF, Woensdregt K, Lambregts DM, et al. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery. Br J Surg. 2019;106:491–8. ID - ref98 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer. VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER -